Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.

16 Jun 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.

16 Jun 2011

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease.

16 Jun 2011

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.

16 Jun 2011

Spectrum board authorizes $25 million stock repurchase program

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that its Board of Directors has authorized the purchase of up to $25 million of its common stock through the end of 2012.

15 Jun 2011

Ethicon Endo-Surgery receives FDA 510(k) clearance for Advanced Energy Generator

In an effort to help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) today announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advanced bipolar technologies and designed for easy set set-up and use in the operating room.

15 Jun 2011

Ethicon Endo-Surgery introduces ENSEAL G2 Super Jaw advanced bipolar technology

To address surgeons' need for achieving strong vessel seals while remaining gentle on tissue in open surgery, Ethicon Endo-Surgery, Inc. (EES) today announces the launch of its innovative ENSEAL® G2 Super Jaw advanced bipolar technology.

15 Jun 2011

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy, announced today it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the TrueBeam™ system for image-guided radiotherapy and radiosurgery in Japan.

15 Jun 2011

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

The Russian CRO market is set to emerge as a distinct competitor in the global CRO market, expected to report yearly growth of 9.5% between 2009 and 2017, according to a new report on companiesandmarkets.com.

15 Jun 2011

APP announces $38 million expansion of New York manufacturing facility

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today a $38 million expansion of its Grand Island, New York manufacturing facility.

15 Jun 2011

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero induces a robust immune response to meningococcal serogroup B when given alone or when co-administered with other routine vaccines.

15 Jun 2011

immatics initiates IMA901 Phase III trial in renal cell carcinoma

igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.

15 Jun 2011

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians.

15 Jun 2011

Actelion awards grants to 2011 ENTELLIGENCE young investigators for research in pulmonary arterial hypertension

Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors for their efforts in advancing research in PAH. Each researcher will receive a 12-month mentored grant of up to $100,000 in support, funded through the ENTELLIGENCE program supported by Actelion. The announcement was made at an awards luncheon, during which the recipients of the 2011 awards gave an overview of their proposed work.

14 Jun 2011

CTI completes pixantrone NDA resubmission meeting with FDA's Division of Oncology Drug Products

Cell Therapeutics, Inc. today announced that it met with the U.S. Food and Drug Administration's Division of Oncology Drug Products.

14 Jun 2011

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced it has entered into an agreement with Life Technologies Corporation that will underpin a new program to provide next-generation sequencing analysis of solid tumors.

14 Jun 2011

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor.

14 Jun 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.

14 Jun 2011

Oncology News and Research

Further Reading

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Spectrum board authorizes $25 million stock repurchase program

Ethicon Endo-Surgery receives FDA 510(k) clearance for Advanced Energy Generator

Ethicon Endo-Surgery introduces ENSEAL G2 Super Jaw advanced bipolar technology

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

APP announces $38 million expansion of New York manufacturing facility

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

immatics initiates IMA901 Phase III trial in renal cell carcinoma

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

Actelion awards grants to 2011 ENTELLIGENCE young investigators for research in pulmonary arterial hypertension

CTI completes pixantrone NDA resubmission meeting with FDA's Division of Oncology Drug Products

Life Technologies, Fox Chase partner to provide next-generation sequencing analysis of solid tumors

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News